$NVAX Company News Novavax Inc. up 16% in

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$NVAX Company News






Novavax Inc. up 16% in premarket
6:52 a.m. Oct. 25, 2012
- Steve Gelsi




Novavax gains 11% on flu vaccine update
11:29 a.m. July 25, 2012
- Val Brickates Kennedy




Tuesday’s biggest gainers and decliners
6:42 p.m. March 1, 2011
- Kate Gibson




Novavax grabs drug-stock spotlight
12:49 p.m. March 1, 2011
- Val Brickates Kennedy




Novavax shares rally on government contract
10:03 a.m. March 1, 2011
- Val Brickates Kennedy




Tuesday's biggest gaining and declining stocks
3:38 p.m. July 27, 2010
- MarketWatch




Baxter, Affymetrix lead drug stocks lower
1:05 p.m. April 22, 2010
- Val Brickates Kennedy




Wednesday's biggest gaining and declining stocks
3:56 p.m. March 24, 2010
- MarketWatch




Poniard, Genzyme lead drug stocks south
10:10 a.m. March 24, 2010
- Val Brickates Kennedy




Drug stocks turn higher; Shire, XenoPort gain
12:59 p.m. Feb. 19, 2010
- Val Brickates Kennedy




Monday's biggest gaining and declining stocks
5:16 p.m. Feb. 8, 2010
- MarketWatch




Drug stocks turn higher; Cell Therapeutics tumbles
1:14 p.m. Feb. 8, 2010
- Val Brickates Kennedy




Novavax shares down 9%
9:37 a.m. Feb. 8, 2010
- Nick Godt




Novavax, Rovi end flu-vaccine-development plan
2:27 a.m. Feb. 8, 2010
- Robert Daniel




Novavax raises $21 million in stock offering
9:10 a.m. Dec. 9, 2009
- Val Brickates Kennedy




Dyax, Santarus, CytRx soar; Hemispherx craters
11:38 a.m. Dec. 2, 2009
- Val Brickates Kennedy




Drug stocks split; Theravance slides on setback
1:22 p.m. Nov. 30, 2009
- Val Brickates Kennedy




Novavax sees Phase III vaccine testing in 2010
9:32 a.m. Nov. 30, 2009
- Val Brickates Kennedy




Inovio, Merck gain; Novavax falls
4:26 p.m. Nov. 20, 2009
- Val Brickates Kennedy




Friday's biggest gaining and declining stocks
4:25 p.m. Nov. 20, 2009
- MarketWatch











Trade-Ideas: Novavax (NVAX) Is Today's "Dead Cat Bounce" Stock

9:46 a.m. Feb. 3, 2014
- TheStreet.com





Novavax (NVAX) in Focus: Stock Tumbles 8.3% - Tale of the Tape

8:36 a.m. Jan. 28, 2014
- Zacks.com





First Week Of March 22nd Options Trading For Novavax (NVAX)

1:21 p.m. Jan. 22, 2014
- TheStreet.com





Can Novavax (NVAX) Continue to Rise? - Tale of the Tape

9:45 a.m. Jan. 20, 2014
- Zacks.com





Novavax:A Biotech Story Set To Double In 2014

2:46 p.m. Jan. 13, 2014
- Seeking Alpha





Novavax Announces Management Promotions

1:50 p.m. Jan. 13, 2014
- benzinga.com





EXCLUSIVE: No Imminent Widespread Outbreak of Human-to-Human Transmitted Avian Flu Expected

5:48 p.m. Jan. 12, 2014
- benzinga.com





Buyout Picks In Healthcare For 2014

7:05 a.m. Jan. 10, 2014
- Seeking Alpha





Positioning For 2014 In The Health Care Sector

8:04 a.m. Jan. 6, 2014
- Seeking Alpha




Biotech Stocks Under $10 With Huge Upside Potential for 2014
7:39 a.m. Jan. 3, 2014
- 247WallSt.com





The Billion-Dollar Biotech Club: Speculation Trumped Risk

9:19 a.m. Dec. 30, 2013
- TheStreet.com




Ten Top Stocks Trading Under $10 to Buy for Big 2014 Gains
6:12 a.m. Dec. 27, 2013
- 247WallSt.com




Piper Jaffray Top Stocks to Buy for 2014
7:44 a.m. Dec. 18, 2013
- 247WallSt.com





Perilous Reversal Watch: Novavax (NVAX)

9:50 a.m. Dec. 17, 2013
- TheStreet.com





Mid-Afternoon Market Update: Markets Rise as Twitter Pulls Back

3:07 p.m. Dec. 16, 2013
- benzinga.com





Novavax Share Price Reaches New All-Time High

2:18 p.m. Dec. 16, 2013
- benzinga.com





Novavax jumps, Wedbush sees big upside

11:41 a.m. Dec. 16, 2013
- Seeking Alpha




Five Big Analyst Stock Picks for 2014
7:17 a.m. Dec. 14, 2013
- 247WallSt.com





Can Novavax, Inc. (NVAX) Continue to Rise? - Tale of the Tape

6:24 a.m. Dec. 12, 2013
- Zacks.com





Sell Organovo, Buy Novavax

3:09 a.m. Dec. 11, 2013
- Seeking Alpha










Unaudited Results, Partnerships, and Stock Price Movements - Research Report on Cubist, Novavax, Exelixis, BioCryst, and Foundation Medicine
8:00 a.m. Jan. 16, 2014
- PR Newswire - PRF




Novavax Announces Management Promotions to Support Expanded Clinical Activity in 2014
8:02 a.m. Jan. 13, 2014
- Thomson Reuters ONE




Novavax Announces Continuation of RSV Vaccine Partnership With PATH
8:01 a.m. Jan. 13, 2014
- Thomson Reuters ONE




Novavax Announces Continuation of RSV Vaccine Partnership With PATH
8:01 a.m. Jan. 13, 2014
- GlobeNewswire




Novavax Announces Management Promotions to Support Expanded Clinical Activity in 2014
8:00 a.m. Jan. 13, 2014
- GlobeNewswire




Upcoming Conferences, Share Price Updates, and Leadership Changes - Research Report on Lilly, Allergan, Waters, Novavax, and Supernus Pharmaceuticals
8:00 a.m. Jan. 8, 2014
- PR Newswire




Announcements, Studies, and Corporate Updates by Healthcare Companies - Research Report on Horizon Pharma, Novavax, WuXi PharmaTech, Chelsea Therapeutics, and Anika Therapeutics
8:00 a.m. Dec. 24, 2013
- PR Newswire




Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax
8:00 a.m. Dec. 23, 2013
- PR Newswire




Pre-Market Breakdown: Galena Biopharma Inc., Novavax Inc., Ariad Pharma Inc., and MannKind Corp.
8:00 a.m. Nov. 27, 2013
- PR Newswire




Companies Report Corporate Growth and Positive Clinical Data - Research Report on Humana, Molina Healthcare, Novavax, Kindred Healthcare, and Repligen
8:00 a.m. Nov. 27, 2013
- PR Newswire




Novavax to Present at the 25th Annual Piper Jaffray Healthcare Conference
4:05 p.m. Nov. 26, 2013
- GlobeNewswire




Financial Reports, Partnerships, Settlement Agreements, and Strategic Acquisitions - Research Report on Mallinckrodt, WellCare, Mindray, Oxygen Biotherapeutics, and Novavax
8:00 a.m. Nov. 19, 2013
- PR Newswire




New England Journal of Medicine Publishes Positive Data From Clinical Trial of Novavax' Vaccine Against H7N9 Avian Flu
5:01 p.m. Nov. 13, 2013
- GlobeNewswire




Novavax Reports Third-Quarter 2013 Financial Results
4:10 p.m. Nov. 7, 2013
- GlobeNewswire




ACAD, CRTX, MACK and NVAX added to NASDAQ Healthcare Stock Watch List at EPR
9:29 a.m. Nov. 7, 2013
- ACCESSWIRE




Clinical Trials Results, Financial Results, and Upcoming Earnings Releases- Research Report on Teleflex, Oxygen Biotherapeutics, Novavax, Prana Biotechnology and Hanger Orthopedic
8:00 a.m. Nov. 4, 2013
- PR Newswire




Morning Research: Ariad Pharma Inc., MannKind Corp., Novavax Inc., and Galena Biopharma Inc.
12:30 p.m. Nov. 1, 2013
- PR Newswire




Novavax to Report Third Quarter 2013 Financial Results on November 7, 2013
3:58 p.m. Oct. 30, 2013
- GlobeNewswire




Pre-Market Review: MannKind Corp., Galena Biopharma Inc., Ariad Pharmaceuticals Inc., and Novavax Inc.
2:40 p.m. Oct. 10, 2013
- PR Newswire




Product Development Strategies, FDA Approval, Incremental Agreement, New Clinical Studies, and Other Announcements - Research Report on Amarin, Discovery Labs, Auxilium, Novavax, and Accuray
7:00 a.m. Oct. 9, 2013
- PR Newswire




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 6

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 5

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 7

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 3

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 7

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading

Top 5 Most Recently Viewed Articles

Kyrgyzstan Introduces BNB Chain-Based Stablecoin Initiative

Updated Category News Views 171

Kyrgyzstan's New National Stablecoin Kyrgyzstan has made a significant move by launching a national stablecoin using the BNB Chain. This exciting development was confirmed by Changpeng "CZ" Zhao, the co-founder of Binance, highlighting a new era in the country's financial landscape. Details of the BNB Chain Stablecoin The stablecoin will be pegged to the national...

Continue Reading
Cytokinetics Begins Exciting Clinical Trial for CK-4015089

Updated Category News Views 187

Cytokinetics Launches Phase 1 Clinical Study of CK-4015089 Advancement of Fast Skeletal Muscle Troponin Activator Expands Pipeline of Muscle-Directed Drug Candidates Cytokinetics, Incorporated (NASDAQ: CYTK) recently announced an important milestone in its research journey. The company has officially launched the Phase 1 clinical study for CK-4015089 (CK-089), a promising...

Continue Reading
MGM Resorts Faces Challenges with Q3 Earnings Miss

Updated Category News Views 98

MGM Resorts Reports Disappointing Third Quarter Earnings MGM Resorts International (NYSE: MGM) released its third-quarter financial results, revealing performance that fell short of expectations. The announcement came after the market closed, and it has led to a notable reaction in the stock market. The Financial Summary In the latest quarter, MGM Resorts reported...

Continue Reading
Emerging Cultures Market Expected to Surpass $2.2 Billion

Updated Category News Views 96

The Promising Growth of the Global Cultures Market The global cultures market is on an impressive growth trajectory, fuelled by a surge in demand for innovative applications across various sectors, particularly food and pharmaceuticals. Market Overview and Growth Projections Current estimates suggest that the cultures market, which stood at USD 1,208.1 million a few years...

Continue Reading
Investors Have Chance to Join Class Action Against Jayud

Updated Category News Views 151

Investors Encouraged to Participate in Jayud Global Lawsuit Investors have a valuable opportunity to take a stand against potential misconduct within Jayud Global Logistics Limited (NASDAQ: JYD). Many shareholders who acquired securities during a specific period are being urged to come forward and join a class action lawsuit initiated by The Schall Law Firm. This action...

Continue Reading